This result was later challenged by Koyama et al. [36], who compared DMOG and roxadustat as PHD inhibitors in LLC tumor models, and showed clear tumor vessel normalization and rescue of chemotherapy sensitivity in tumor-bearing mice challenged with the compounds [36,162]. Here, PDC is linked to neoplasm.